Intraperitoneal (IP) Chemotherapy
01 January 2025
Intraperitoneal (IP) Chemotherapy - Now Available at Sunway Medical Centre, Sunway City
This cutting-edge cancer treatment delivers chemotherapy directly into the abdomen (peritoneal cavity) for maximum effectiveness.
Who Can Benefit from This Treatment?
IP Chemotherapy is commonly used for cancers affecting the abdominal organs, such as:
- Ovarian cancer
- Primary peritoneal cancer
- Gastric cancer with peritoneal disease
Benefits of IP Chemotherapy
- Targeted treatment: Directly targets cancer cells in the abdomen
- Higher Drug Concentration: Higher doses of chemotherapy can be delivered intraperitoneally compared to intravenous administration
- Reduced Systemic Toxicity: Since IP chemotherapy is localised, there may be less systemic absorption into the bloodstream, potentially reducing the overall side effects typically associated with intravenous chemotherapy.
- Improved Survival Rates: Studies have shown that in certain cases like advanced ovarian cancer, IP chemotherapy can significantly improve survival rates compared to traditional intravenous chemotherapy alone.
How Is IP Chemotherapy Administered?
- A small device, called a port, is surgically placed under your skin near your rib cage.
- During treatment, a needle is inserted into the port to deliver the chemotherapy drug directly to the tumour site, potentially increasing effectiveness.
Interested to Learn More?
Contact us today to discuss how IP Chemotherapy can help you or a loved one in the fight against cancer: wa.me/60192971185
Back
